In the cohort, patients who developed AKI were elder and exhibited more comorbidities (diabetes mellitus, anemia, and CHF) and lower levels of lymphocyte, serum albumin, eGFR, and haematocrit compared with those who did not develop AKI. This evidence concerns the gene ALB and anemia.